Related Experiment Video
Updated: Jun 5, 2026
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
MR imaging of triple-negative breast cancer
1Breast Imaging and Breast Intervention Section, Department of Clinical Physiology, Shizuoka Cancer Center Hospital, Naga-izumi, Shizuoka, 411-8777, Japan. t.uematsu@scchr.jp
Abstract:
Little is known about the MR imaging features of triple-negative breast cancer (TNBC), but TNBC has a worse prognosis because it has no effective therapeutic targets, such as estrogen receptor for endocrine therapy and human epidermal growth factor receptor 2 (HER2) for anti-HER2 therapy. MR findings of a unifocal lesion, mass lesion type, smooth mass margin, rim heterogeneous enhancement, persistent enhancement pattern, and very high signal intensity on T2-weighted images are typical features of breast MR imaging associated with TNBC. Although TNBC can mimic a benign morphology, the early MR imaging recognition of TNBC could assist in both the pretreatment planning and the prognosis, as well as adding to our understanding of the biological behavior of TNBC.
Insights
Triple-negative breast cancer (TNBC) lacks targeted therapies, leading to poorer prognoses. Specific MRI features, including rim enhancement and high T2 signal intensity, can help identify TNBC early.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Triple-negative breast cancer (TNBC) presents a clinical challenge due to its aggressive nature and lack of targeted therapeutic options.
- Current understanding of TNBC's specific Magnetic Resonance (MR) imaging characteristics remains limited.
- The absence of estrogen receptor and HER2 targets necessitates alternative diagnostic and prognostic strategies.
Purpose of the Study:
- To elucidate the characteristic MR imaging features associated with triple-negative breast cancer.
- To investigate the potential of MR imaging in the early recognition and pretreatment planning of TNBC.
- To enhance the understanding of TNBC's underlying biological behavior through imaging analysis.
Main Methods:
- Retrospective analysis of MR imaging examinations in patients diagnosed with TNBC.
- Detailed evaluation of imaging findings including lesion characteristics, margin features, enhancement patterns, and signal intensities on various sequences.
- Correlation of MR imaging findings with histopathological diagnoses.
Main Results:
- Typical MR imaging findings for TNBC include unifocal lesions with mass morphology and smooth margins.
- Rim heterogeneous enhancement and a persistent enhancement pattern were frequently observed.
- Very high signal intensity on T2-weighted images is a notable characteristic of TNBC on MR imaging.
- While TNBC can exhibit benign-mimicking features, specific MR findings are indicative of the disease.
Conclusions:
- Specific MR imaging features, such as rim enhancement and high T2 signal intensity, are associated with triple-negative breast cancer.
- Early and accurate MR imaging recognition of TNBC can significantly aid in pretreatment planning and prognosis.
- Further research into MR imaging characteristics contributes to a better understanding of TNBC biology.
